- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Turmeric supplementation complementary treatment managing disturbed glycemia
Iran: A grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials (RCTs) have shed light on the effects of curcumin/turmeric supplementation on glycemic indices in adults.
The results published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews indicate that turmeric/curcumin supplementation can be considered a complementary method for managing disturbed glycemia.
Turmeric is an herb used as a colouring agent in Iranian cuisine. Also, it has been used as a traditional remedy for several ailments; such as arthritis and injuries. Curcumin is believed to be the most potent bioactive compound of turmeric. Several studies have revealed that curcumin extracted from the herb is effective in reducing the symptoms of a variety of medical conditions.
Glycemic control is of critical importance both as a preventive measure in people at risk of diabetes and patients' management with disturbed glycemia. In this field, curcumin/turmeric has been extensively studied. In the systematic review and meta-analysis, Moein Askarpour, Shiraz University of Medical Sciences, Shiraz, Iran, and colleagues aimed to investigate the impact of turmeric/curcumin supplementation on glycemic control.
For this purpose, the researchers systematically searched the major online databases from inception up to October 2022. The researchers included relevant RCTs meeting the eligibility criteria. Weighted mean differences (WMDs) were expressed using a random-effect model. To determine the sources of heterogeneities, they conducted subgroup analyses. The Cochrane risk-of-bias tool was used to detect the risk of bias in the included studies.
The authors reported the following findings:
- Out of 4182 articles retrieved from the initial search, 59 RCTs were included.
- The findings suggested that turmeric/curcumin supplementation was significantly effective in improving fasting blood sugar (WMD: 4.60 mg/dl), haemoglobin A1c (HbA1c) (WMD: 0.32%), fasting insulin levels (WMD: 0.87 μIU/ml), and homeostatic model assessment of insulin resistance (HOMA-IR) (WMD: 0.33).
"Our results indicate that supplementation with turmeric/curcumin can be considered a complementary method in managing disturbed glycemia," the researchers concluded.
Reference:
Dehzad, M. J., Ghalandari, H., Nouri, M., & Askarpour, M. (2023). Effects of curcumin/turmeric supplementation on glycemic indices in adults: A grade-assessed systematic review and dose–response meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 17(10), 102855. https://doi.org/10.1016/j.dsx.2023.102855
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751